2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications

被引：7

作者：

Chatterjee, S ^{[1
]}

Gallen, IW ^{[1
]}

Sandler, L ^{[1
]}

机构：

[1] Wycombe Hosp, Ciltern Diabet Ctr, High Wycombe HP11 2TT, Bucks, England

来源：

DIABETES CARE | 1999年 / 22卷 / 07期

关键词：

D O I：

10.2337/diacare.22.7.1226

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1226 / 1227

页数：2

共 6 条

[1] Strategies toward improved control during insulin lispro therapy in IDDM - Importance of basal insulin [J].

Ebeling, P ;

Jansson, PA ;

Smith, U ;

Lalli, C ;

Bolli, GB ;

Koivisto, VA .

DIABETES CARE, 1997, 20 (08) :1287-1289

[2] Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes [J].

Feinglos, MN ;

Thacker, CH ;

English, J ;

Bethel, MA ;

Lane, JD .

DIABETES CARE, 1997, 20 (10) :1539-1542

[3] The human insulin analogue insulin lispro [J].

Koivisto, VA .

ANNALS OF MEDICINE, 1998, 30 (03) :260-266

[4] Health-related quality-of-life results from multinational clinical trials of insulin lispro - Assessing benefits of a new diabetes therapy [J].

Kotsanos, JG ;

Vignati, L ;

Huster, W ;

Andrejasich, C ;

Boggs, MB ;

Jacobson, AM ;

Marrero, D ;

Mathias, SD ;

Patrick, SD ;

Zalani, S ;

Anderson, J .

DIABETES CARE, 1997, 20 (06) :948-958

[5] Insulin lispro in CSII - Results of a double-blind crossover study [J].

Zinman, B ;

Tildesley, H ;

Chiasson, JL ;

Tsui, E ;

Strack, T .

DIABETES, 1997, 46 (03) :440-443

[6]

ZINMAN B, 1997, DIABETES S1, V46, pA43

← 1 →